---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-001163"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T04:43:52.835899+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health appoints Timothy Wern as EVP Sales after Hendricks departure

## Summary
- Timothy Hendricks separated as EVP of Sales effective January 3, 2025.
- Timothy Wern appointed EVP of Sales effective January 6, 2025.
- Wern has sales leadership experience at HeartWare, Abiomed, and Ceevra.
- Separation agreement terms with Hendricks are still being negotiated.

## SEC filing metadata
- accession: 0001628280-25-001163
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025001163/0001628280-25-001163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025001163/snwv-20250103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-001163
- JSON: https://secwatch.observer/filing/0001628280-25-001163.json
- Plain text: https://secwatch.observer/filing/0001628280-25-001163.txt

## Key facts
- Executive change
  Timothy Hendricks departed as Executive Vice President of Sales at SANUWAVE Health, Inc..
  - Action: separated from service
  - Role: Executive Vice President of Sales
  source text: On January 3, 2025, Timothy Hendricks separated from service as Executive Vice President of Sales of Sanuwave Health, Inc. (the “ Company ”), effective as of the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000162828025001163/0001628280-25-001163-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.